Discover 484 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 484
FeaturedActive & Responsive
Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety
for
Depression
Location: Providence RI
Sponsor: Ocean State Research Institute, Inc.
Sex: All
Age: 22 - 70+
Code: NCT05147142
Recruiting
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: Wakefield RI, Bronx NY, Philadelphia PA, Pittsburgh PA,
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Brooklyn NY, East Syracuse NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
Location: East Greenwich RI, Brookline MA, Burlington MA,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT06592794
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
for
SARS-CoV-2
Location: East Greenwich RI, Methuen MA, Bridgeport CT,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 50 - 64
Code: NCT07266558
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
TMS + Exposure Therapy for Pediatric OCD
for
Obsessive-Compulsive Disorder
Location: Riverside RI, Minneapolis MN
Sponsor: Bradley Hospital
Sex: All
Age: 12 - 21
Code: NCT05931913
Recruiting
Active & Responsive
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease